BiotechTube
Home/Castle Biosciences/Dana Oliver
DO

Dana Oliver

Chief Commercial Officer

Castle Biosciences

Therapeutic Areas

OncologyGastroenterologyDermatology

Castle Biosciences Pipeline

DrugIndicationPhase
DecisionDx-Melanoma (i31-SLNB)Cutaneous Melanoma (Stage I-III)Commercial/Ongoing Validation
DecisionDx-SCCCutaneous Squamous Cell CarcinomaCommercial/Ongoing Validation
DecisionDx-UM & PRAMEUveal MelanomaCommercial/Ongoing Validation
TissueCypherBarrett’s EsophagusCommercial/Ongoing Validation
MyPath MelanomaDifficult-to-Diagnose Melanocytic LesionsCommercial/Ongoing Validation
IDgenix (AdvanceAD Tx)Moderate-to-Severe Atopic DermatitisCommercial/Early Launch

Leadership Team at Castle Biosciences

DM
Derek Maetzold
Founder, President & CEO
FS
Frank Stokes
Chief Financial Officer
RC
Robert Cook
Chief Legal Officer & Corporate Secretary
ML
Matthew Leavitt, M.D.
Chief Medical Officer
View full Castle Biosciences profile